Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis
Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis. // Biochimica et Biophysica Acta: Molecular Cell Research. – URL: https://www.sciencedirect.com/science/article/pii/S0167488926001230?dgcid=rss_sd_all
Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis. Biochimica et Biophysica Acta: Molecular Cell Research. https://www.sciencedirect.com/science/article/pii/S0167488926001230?dgcid=rss_sd_all
“Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis.” Biochimica et Biophysica Acta: Molecular Cell Research.
@article{article1540,
title = {Upamostat potentiates bortezomib cytotoxicity and delays proteasome recovery in bortezomib-resistant malignant lymphoma cells through modulation of the DDI2/NRF1 axis},
journal = {Biochimica et Biophysica Acta: Molecular Cell Research},
url = {https://www.sciencedirect.com/science/article/pii/S0167488926001230?dgcid=rss_sd_all}
}
Nature Cell Biology, Published online: 16 November 2026; doi:10.1038/s41556-026-02154-w Author Correction: Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and...